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ABSTRACT
ObjectiveTocomparetheclinicalefficacyoffootorthoses
in the managementofpatellofemoralpainsyndromewith
flat inserts or physiotherapy, and to investigate the
effectiveness of foot orthoses plus physiotherapy.
DesignProspective,singleblind,randomisedclinicaltrial.
Setting Single centre trial within a community setting in
Brisbane, Australia.
Participants 179 participants (100 women) aged 18 to
40 years, with a clinical diagnosis of patellofemoral pain
syndromeofgreaterthansixweeks’duration,whohadno
previoustreatmentwithfootorthosesorphysiotherapyin
the preceding 12 months.
Interventions Six weeks of physiotherapist intervention
with off the shelf foot orthoses, flat inserts, multimodal
physiotherapy(patellofemoraljointmobilisation,patellar
taping, quadriceps muscle retraining, and education), or
foot orthoses plus physiotherapy.
Main outcomemeasures Global improvement, severity of
usual and worst pain over the preceding week, anterior
knee pain scale, and functional index questionnaire
measured at 6, 12, and 52 weeks.
ResultsFootorthosesproducedimprovementbeyondthat
of flat inserts in the short term, notably at six weeks
(relativeriskreduction0.66,99%confidenceinterval0.05
to 1.17; NNT 4 (99% confidence interval 2 to 51). No
significant differences were found between foot orthoses
and physiotherapy, or between physiotherapy and
physiotherapyplusorthoses.Allgroupsshowedclinically
meaningful improvements in primary outcomes over
52 weeks.
ConclusionWhilefootorthosesaresuperiortoflatinserts
according to participants’ overall perception, they are
similar to physiotherapy and do not improve outcomes
when added to physiotherapy in the short term
management of patellofemoral pain. Given the long term
improvement observed in all treatment groups, general
practitioners may seek to hasten recovery by prescribing
prefabricated orthoses.
Trial registration Australian Clinical Trials Registry
ACTRN012605000463673 and ClinicalTrials.gov
NCT00118521.
INTRODUCTION
Patellofemoral pain syndrome, or idiopathic pain
arising from the anterior knee,
1 is one of the most
common musculoskeletal presentations to general
practice
2 and sports medicine clinics.
3-8 In a retro-
spective survey of 2002 runners presenting to a sports
medicine centre, patellofemoral pain syndrome
accounted for 19% of running injuries,
9 whereas a
twoyearprospectivecohortstudyreportedonsetofthe
syndrome in 9% of 282 students of physical education
aged 17-21.
10 The pain is characteristically provoked
by activities such as squatting, stair walking, and
running, and hence impacts on many aspects of daily
life, including the ability to perform pain free exercise
or work related activities. Patellofemoral pain syn-
drome can result in repeat visits to a doctor given its
tendency towards chronicity, with 94% of patients
continuing to experience pain up to four years after
initial presentation and 25% reporting significant
symptoms up to 20 years later.
11
Despite the prevalence, chronicity, and impact of
patellofemoral pain syndrome, several systematic
reviews of interventions attest to a dearth of high
quality research on management.
12-17 One study
concluded that the available evidence at that time
wouldleadthepractitionertoimplementaprogramme
ofeducation,stretching,andstrengtheningofthethigh
muscles, and possibly foot orthoses.
15 Subsequently a
high quality randomised controlled trial found that a
multimodalphysiotherapy programmeforsix weeks
18
wasmoreeffectivethanshamtreatment:relativeriskof
noticeableimprovement3.39(95%confidenceinterval
1.69 to 6.80).
19 That study did not, however, compare
physiotherapy with the control sham intervention
beyond six weeks.
As an alternative or adjunct to physiotherapy, foot
orthosesarecommonlyusedtotreatactivepeoplewith
patellofemoral pain syndrome. Recently, a systematic
reviewoftheclinicalefficacyoffootorthosesidentified
two small clinical trials in people with patellofemoral
pain syndrome.
20 These studies suggest that foot
orthoses may be of benefit.
2122 No high quality
randomised controlled trials have evaluated the use
of foot orthoses for treating patellofemoral pain
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the use of foot orthoses for this common clinical
conditionisimperativeconsideringthewidespreaduse
of foot orthoses and the lack of consensus and
controversy surrounding their prescription.
2324
We evaluated the short and long term clinical
efficacy of prefabricated foot orthoses in the treatment
of patellofemoral pain syndrome compared with flat
inserts or physiotherapy alone, and evaluated whether
orthoses improved the effects of physiotherapy. We
hypothesised that foot orthoses would be superior to
flatinsertsandequivalenttophysiotherapyandthatthe
combinationoffootorthosesandphysiotherapywould
be superior to physiotherapy alone.
METHODS
We carried out a pragmatic, single blind, randomised
clinicaltrialinacommunitysettingfor12months.The
methods have been described in detail previously.
25
Volunteers from the greater Brisbane, Gold Coast,
and Toowoomba regions of Queensland, Australia
respondedto advertisements in print media, radioand
television media releases, noticeboards, and referrals
from practitioners. Eligibility criteria were based on a
previousclinicaltrial
19:age18-40years;insidiousonset
ofanteriorkneeorretropatellarpainofgreaterthansix
weeks’ duration and provoked by at least two of
prolonged sitting or kneeling, squatting, running,
hopping, or stair walking; tenderness on palpation of
thepatella,orpainwithstepdownordoublelegsquat;
andworstpainoverthepreviousweekofatleast30mm
on a 100 mm visual analogue scale. Exclusion criteria
were concomitant injury or pain from the hip, lumbar
spine,or other kneestructures; previousknee surgery;
patellofemoralinstability; knee joint effusion;any foot
conditionthatprecludeduseoffootorthoses;allergyto
strapping tape; use of physiotherapy or foot orthoses
within the previous year; or use of anti-inflammatory
drugs.
Protocol
To facilitate concealment of allocation, a blinded
assessor not involved in the randomisation process
determined eligibility. The randomisation sequence
wasdrawnupandkeptoffsitebyanindependentbody,
using a random number generator in blocks of eight
with no stratification. Participants gave written
informed consent and, after we had obtained baseline
measures, were randomly assigned to receive one of
four treatments: foot orthoses, flat inserts, physio-
therapy, or foot orthoses plus physiotherapy. A
research assistant communicated with the randomisa-
tion centre, participants, and project physiotherapists
throughout the trial, thus ensuring that the assessor
responsible for outcome measurement and data
analysis remained blind to group allocation.
Interventions
Interventions were administered by one of 17 regis-
tered physiotherapists who underwent training for
each treatment protocol. Participants attended six
appointments of 20-60 minutes’ duration over six
weeks, after which they were encouraged to continue
with a self management programme.
The intervention programmes have been detailed
previously.
25 In brief, participants assigned to foot
orthoses received prefabricated, commercially avail-
able orthoses (Vasyli International), which were fitted
to their shoes with comfort as a primary goal. These
orthoses are customisable to some degree to optimise
comfort through heat moulding and by adding wedge
or heel raises. As a control for these orthoses we used
flat inserts, manufactured from the same material
(ethylenevinyl acetate) with identical covering fabric.
These were of uniform thickness, with no inbuilt arch
or wedging. Physiotherapy consisted of a combined
Excluded (n=1034):
  Did not meet inclusion criteria (n=484)
  Met exclusion criteria (n=360)
  Declined to participate (n=9)
  Did not attend or cancelled screening appointment (n=68)
  Unable to be contacted (n=102)
  Other (n=11)
Telephone screening (n=1530)
Physical screening (n=496)
Randomisation (n=179)
Flat inserts (n=44)
Received allocated
intervention (n=36)
Did not receive
intervention
according to protocol:
attended fewer than
6 sessions (n=6)
Crossed over to
foot orthoses at
12 weeks (n=2)
Foot orthoses (n=46)
Received allocated
intervention (n=41)
Did not receive
intervention
according to protocol:
attended fewer than
6 sessions (n=5)
Physiotherapy (n=45)
Received allocated
intervention (n=41)
Did not receive
intervention
according to protocol:
attended fewer than
6 sessions (n=4)
Foot orthoses plus
physiotherapy (n=44)
Received allocated
intervention (n=39)
Did not receive
intervention
according to protocol:
attended fewer than
6 sessions (n=5)
Follow-up:
6 weeks (n=42)
12 weeks (n=40)
52 weeks (n=43)
Follow-up:
6 weeks (n=41)
12 weeks (n=41)
52 weeks (n=42)
Follow-up:
6 weeks (n=41)
12 weeks (n=42)
52 weeks (n=45)
Follow-up:
6 weeks (n=40)
12 weeks (n=38)
52 weeks (n=41)
Completed trial (n=43)
Lost to follow-up:
unable to be
contacted (n=1)
Completed trial (n=42)
Lost to follow-up:
unable to be
contacted (n=3)
Completed trial (n=45)
Lost to follow-up:
died (n=1)
Completed trial (n=41)
Lost to follow-up:
unable to be
contacted (n=3)
Analysed (n=43)
Excluded from
analysis (n=0)
Analysed (n=42)
Excluded from
analysis (n=0)
Analysed (n=45)
Excluded from
analysis (n=0)
Analysed (n=41)
Excluded from
analysis (n=0)
Excluded (n=313):
  Did not meet inclusion criteria (n=122)
  Met exclusion criteria (n=144)
  Declined to participate (n=16)
  Did not attend or cancelled baseline appointment (n=6)
  Unable to be contacted (n=6)
  Other (n=19)
Pilot participants (n=4)
Informed consent
Baseline outcome measures
Fig 1 | Flow of participants through study
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patellofemoral pain syndrome
19 and included patellar
mobilisation,patellartaping,aprogressiveprogramme
of vasti muscle retraining exercises with electromyo-
graphic biofeedback, hamstring and anterior hip
stretches, hip external rotator retraining, and a home
exercise programme.Participants assigned to orthoses
plus physiotherapy received both interventions as
described and had an extra appointment with the
physiotherapistifmoretimewasrequiredforadequate
delivery of all treatment components.
The participants were encouraged to continue
exercise and activities that did not provoke their pain.
The use of non-study interventions was discouraged
throughout the trial, although over the counter drugs
were permitted. Any cointerventions used for symp-
toms of patellofemoral pain syndrome, as well as any
adverse effects arising from intervention, were
recorded in diaries, reported to the research assistant,
or detailed in an exit questionnaire.
Outcomes
The blinded assessor carried out reliable and valid
outcomemeasures
2526beforerandomisation(baseline)
and at 6, 12, and 52 weeks after randomisation. The
primary outcome measures were global
improvement,
25 severity of usual and worst pain over
theprecedingweek,theanteriorkneepainscale,
27and
the functional index questionnaire.
28 We measured
global improvement on a five point Likert scale
(“marked improvement” to “marked worsening”) and
visualanaloguescale(−100mm=muchworse,0=same,
100=completely better). We reduced categorical data
to success equating marked or moderate
improvement.
19
Sample size
We based the sample size calculations on a clinically
meaningfulimprovementof15 mmona 100 mmpain
visual analogue scale for usual pain.
2629 Assuming a
standarddeviationof20mm,
19apowerof0.80,andan
α level of 0.01, we required 40 participants in each
group.Weincreasedthesamplesizeby10%,to176(44
in each group), to allow for loss to follow-up.
Statistical analysis
Statistical analysis was done on a blinded, intention to
treat basis using SPSS software (version 15.0). We
chosetheprimaryendpointsof6,12,and52weeks,as
six weeks (immediately after the treatment period)
could be considered to be the time of greatest effect,
12 weeks is a standard follow-up time in studies of
patellofemoral pain syndrome,
30-33 and the long term
(52 weeks) efficacy of foot orthoses or this specific
physiotherapy programme has not been investigated.
Thedichotomousmeasureofsuccesswasexpressedas
relative risk reduction and numbers needed to treat.
We analysed continuous outcome measures using
univariate analysis of covariance, with baseline as a
covariate and group allocation as a fixed factor. We
included the characteristics of the participants and
other baseline outcome measures as covariates in
statistical models to determine their impact on out-
come.Significancewassetat0.01toaccommodatethe
possibilityofaninflatedtypeIerrorrateresultingfrom
multiple comparisons.
RESULTS
From May 2004 to May 2006, 1530 volunteers were
screenedand 179enrolledinthe study(fig1). Thetrial
was completed in June 2007, with 164 participants
(92%) followedup atsix weeks, 161 (90%)at 12 weeks,
and 171 (96%) at 52 weeks. With the exception of
duration, all groups were well matched at baseline
(table 1). Including baseline data as covariates did not
significantly influence outcomes.
Significant effects favoured foot orthoses over flat
inserts at six weeks, with differences of 19.8 mm (99%
Table 1 |Baselinecharacteristicsofparticipantsforinterventiongroupsandstudycohort.Valuesaremean(SD)unlessstated
otherwise
Characteristics
Foot orthoses
(n=46)
Flat inserts
(n=44)
Physiotherapy
(n=45)
Foot orthoses plus
physiotherapy (n=44) Total (n=179)
Age (years) 27.9 (5.3) 29 (6.0) 30.9 (5.8) 29.6 (5.6) 29.3 (5.8)
No (%) of women 25 (54.3) 20 (45.5) 29 (64.4) 26 (59.1) 100 (55.9)
Height (cm) 172.8 (9.1) 174.9 (10.5) 170.9 (8.4) 173.3 (9.6) 173 (9.5)
Weight (kg) 78.5 (20.4) 73.8 (15.9) 70.9 (14.6) 75.2 (22.3) 74.7 (18.6)
Body mass index 26.1 (5.6) 23.9 (3.5) 24.2 (4.7) 24.8 (6.2) 24.8 (5.1)
Physical activity* (kcal/kg) 40.6 (7.1) 41.3 (7) 41.2 (7.3) 40.8 (8.1) 41 (7.3)
No (%) with bilateral knee pain 26 (56.5) 25 (56.8) 26 (57.8) 25 (56.8) 102 (57)
Median(interquartilerange)duration
of knee pain (months)
42 (12.3-96) 24 (12-71) 37 (12.3-84.8) 24 (9-60) 28 (12-84)
Usual pain† 38.6 (16) 32.8 (15.1) 34.1 (17.0) 39.8 (17.6) 36.3 (16.6)
Worst pain† 59.4 (15.3) 56.6 (14.9) 61.4 (15.6) 64.8 (17.0) 60.5 (15.9)
Anterior knee pain scale‡ 70.8 (9.0) 72.1 (9.3) 71.7 (11.3) 71.5 (9.8) 71.5 (9.8)
Functional index questionnaire§ 10 (1.9) 10 (1.9) 10 (2.6) 9.3 (2.0) 9.8 (2.1)
*Physical activity over previous week questionnaire, total energy expended per day.
†Pain measured on 100 mm visual analogue scale; 0 mm=no pain, 100 mm=worst pain imaginable.
‡0-100 points; 100=no disability.
§0-16 points; 16=no disability.
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of global improvement, a number needed to treat of 4
(2 to 51) on the categorical scale (success equating
markedandmoderateimprovement),andsuccessrates
of85%(35/41)forfootorthosesand58%(23/40)forflat
inserts (fig 2, tables 2 and 3). These trends were
mirroredwhenthecategoricaldataonglobalimprove-
ment were collapsed to success equating marked
improvement at six and 12 weeks. At six and
12 weeks no significant differences were found in
global improvement between physiotherapy and foot
orthoses, or between physiotherapy and combined
physiotherapy and orthoses (tables 2 and 3). For each
ofthethreeaprioripairwisecomparisonsnosignificant
differences were found between the groups on other
outcome measures (table 3).
Over 52 weeks all groups had clinically meaningful
improvementsinworstpainseverity(>20mmonpain
visual analogue scale), anterior knee pain scale (>10
points),andfunctionalindexquestionnaire(>2points;
tables 1 and 3).
26 Three of the four groups (foot
orthoses, physiotherapy, foot orthoses plus physio-
therapy) also had clinically meaningful improvements
in usual pain severity, whereas the improvement in
usual pain for the group receiving flat inserts was
slightly less than 20 mm. No significant differences
werefoundbetweengroupsonanyprimarymeasureat
52 weeks.
Cointerventions
Table 4 outlines the participants’ use of cointerven-
tions.Nosignificantdifferenceswerefoundinreported
rates of use between foot orthoses and flat inserts (14/
40,35%v15/39,38%;relativeriskreduction0.09,99%
confidence interval −0.6 to 0.76), physiotherapy and
footorthoses(16/43,37%v14/40,35%;−0.06,−0.78to
0.68), or foot orthoses plus physiotherapy and physio-
therapy alone (9/40, 23% v 16/43, 37%; 0.4, −0.3 to
1.01). Two participants assigned to flat inserts crossed
over to foot orthoses after 12 weeks.
Side effects
Agreaterproportionofparticipantsreportedmildside
effectswiththefootorthoses(footorthoses31/43,72%;
footorthosesplusphysiotherapy20/41,49%)thanwith
the flat inserts (15/39, 38%; relative risk reduction
−0.58, 99% confidence interval −1.01 to −0.09). These
consisted of rubbing and blistering, discomfort, and
pain in the toes, feet, and ankles, which on the whole
responded to increasing wear and minor adjustments
to the orthoses (for example, heat moulding and
additions) and did not prevent wearing of the orthoses
or inserts. Thirty four participants (physiotherapy 18/
44,41%;footorthosesplusphysiotherapy16/41,39%;
relative risk reduction 0.05, −0.59 to 0.67) reported a
reaction to daily patellar taping (for example, skin
irritation, blistering). Two participants (physiotherapy
group and foot orthoses group) experienced low back
pain that required additional physiotherapy.
DISCUSSION
Foot orthoses produced short term improvements
beyond that of flat inserts, with the number needed to
treat indicating that four patients would need to be
treated with orthoses to have one additional patient
experience improvement in patellofemoral pain. Foot
52 weeks 12 weeks 6 weeks
Orthoses
Flat inserts
Physiotherapy
Orthoses plus physiotherapy
Orthoses
Flat inserts
Physiotherapy
Orthoses plus physiotherapy
Orthoses
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Fig 2 | Percentage of participants rating perceived improvement across categories from marked
improvement to marked worsening
Table 2 |Absoluteeventratesofsuccessofglobaleffectandcomparisonsbetweengroupsfordichotomousmeasureofsuccessexpressedasrelativeriskreductions
andnumbersneededtotreat(NNT)
Follow-up
No (%) moderately or markedly improved* Between group differences (99% CI)†
Foot orthoses Flat inserts Physiotherapy
Foot orthoses plus
physiotherapy
Foot orthoses
v flat inserts
Physiotherapy v foot
orthoses
Foot orthoses plus
physiotherapy v
physiotherapy
6 weeks 35/41 (85) 23/40 (58) 38/41 (93) 38/42 (90) 0.66 (0.05 to 1.17)‡;
NNT 4 (2 to 51)‡†
0.5 (−0.84 to 1.85);
NNT 14 (−8t o4 )
−0.3 (−2.83 to 2.24);
NNT −45 (−5t o6 )
12 weeks 34/42 (81) 30/38 (79) 34/41 (83) 38/40 (95) 0.1 (−0.99 to 1.2);
NNT 50 (−5t o4 )
0.1 (−1.06 to 1.25);
NNT 51 (−5t o4 )
0.71 (−0.44 to 1.87);
NNT 8 (−13 to 3)
52 weeks 38/45 (84) 30/41 (73) 34/42 (81) 35/43 (81) 0.42 (−0.43 to 1.24);
NNT 9 (−9t o3 )
−0.22 (−1.6 to 1.14);
NNT −29 (−4t o6 )
0.02 (−1.13 to 1.18);
NNT 226 (−5t o4 )
*Participants rated improvement on five point Likert scale of global effect.
†Positive point estimate favours first listed condition.
‡Significant at P=0.01.
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combining foot orthoses with physiotherapy did not
provide additional improvement beyond physio-
therapy alone. In the long term, clinically meaningful
improvements occurred in pain and function for all
interventions but no differences were found between
interventions.Theoverallpatternofeffectimpliesthat
footorthosesandphysiotherapyeachhastenresolution
of the condition, which is an important benefit for a
common, chronic condition.
Treatment costs are a further consideration for
practitioners and their patients. Assuming recom-
mended retail pricing, in addition to consultation fees
(usually between two to four consultations), the
orthoses (three pairs, including additions) would cost
$A174 (£79; €100) compared with $A45 for three flat
inserts.Thiswould seemtobea reasonablealternative
to physiotherapy (six sessions at around $A495,
including tape). A cost benefit analysis is required to
investigate this further.
Theinterventionsusedinthistrial,includingthe flat
inserts, produced only mild side effects in the early
phase of treatment. Despite the orthoses having
relatively more minor side effects than the flat inserts,
they showed a greater improvement in the first six
weeks, suggesting that these side effects did not
adversely influence treatment outcomes. About 40%
of participants who received the physiotherapy inter-
vention (with or without foot orthoses) experienced
skin reactions with daily taping of the patella, despite
exclusion of participants with known allergies to tape.
It is difficult to know whether this is abnormally high
due to inadequate reporting in previous trials, but
should be considered in clinical application.
Theprescriptionoffootorthosesformusculoskeletal
pain is characterised by a lack of evidence from high
quality clinical trials.
1520 Our study provided level II
evidence for the use of foot orthoses in patellofemoral
pain syndrome. Our data corroborate findings from a
smaller study of 20 adolescent females aged 13 to 17,
which found statistically significant improvements in
painduringgait,sitting,andsquattingaftereightweeks
of treatment.
21 The authors did not supply point
estimates of effect. Furthermore, the magnitude of the
effect of physiotherapy that we observed on primary
outcome measures at six weeks was comparable with
that of another study.
19
Some authors contend that the contoured form of
foot orthoses is critical for controlling foot motion,
usually excessive pronation.
34-36 This exists despite
threekeyissues,allofwhichimpingeontheconductof
a randomised controlled trial. Firstly, research shows
generally equivocal and non-systematic effects of the
abilityoffootorthosestocontrolmotion.
37-39Secondly,
alternative means may be available by which foot
orthoses exert clinical effects, such as by serving as
space fillers to facilitate full plantar contact,
40 which
some regard to be clinically beneficial.
4142 Thirdly,
previous research has failed to show that people with
patellofemoral pain syndrome have excessive foot
Table3 |Mean(SD)scoresandmeandifference(99%confidenceintervals)betweengroupsforcontinuousprimaryoutcomemeasuresat6,12,and52weeks(adjusted
forbaseline),accordingtointerventionforpatellofemoralpainsyndrome
Variables
Mean (SD) for each group Mean (99% CI) differences between groups
Foot orthoses Flat inserts Physiotherapy
Foot orthoses
plus
physiotherapy
Foot orthoses v flat
inserts
Physiotherapy v
foot orthoses
Foot orthoses plus
physiotherapy v
physiotherapy
Global improvement (−100-100)*:
6 weeks 37.6 (27.2) 17.8 (27.2) 45.4 (27.2) 48.7 (27.2) 19.8 (4.0 to 35.6)† 7.8 (−7.8 to 23.5) 3.2 (−12.3 to 18.8)
12 weeks 46.7 (32.8) 30.6 (32.8) 53.4 (32.8) 61.8 (32.8) 16.1 (−3.0 to 35.3) 6.7 (−12.1 to 25.5) 8.4 (−10.7 to 27.4)
52 weeks 52.3 (39.8) 49.9 (39.8) 54.7 (39.8) 55.2 (39.8) 2.4 (−20.0 to 24.8) 2.4 (−19.9 to 24.7) 0.5 (−22.0 to 23.0)
Usual pain (0-100 mm)‡:
6 weeks 25.4 (17.4) 33.4 (17.5) 21.2 (17.3) 19.4 (17.4) −8( −18.1 to 2.1) −4.2 (−14.2 to 5.8) −1.8 (−11.8 to 8.2)
12 weeks 22.1 (17.8) 24.5 (18) 20.1 (17.8) 16.4 (17.9) −2.4 (−12.9 to 8.1) −2( −12.2 to 8.2) −3.7 (−14.1 to 6.6)
52 weeks 16.2 (18.5) 17.9 (18.6) 13.9 (18.5) 14.4 (18.6) −1.7 (−12.2 to 8.8) −2.2 (−12.6 to 8.1) 0.4 (−10.1 to 10.9)
Worst pain (0-100 mm)‡:
6 weeks 39.8 (21.7) 48 (21.8) 32.2 (21.6) 28.5 (21.9) −8.1 (−20.7 to 4.4) −7.7 (−20.2 to 4.8) −3.6 (−16.0 to 8.8)
12 weeks 33.3 (22.2) 35 (22.4) 26.8 (22.2) 26.5 (22.3) −1.7 (−14.7 to 11.3) −6.5 (−19.2 to 6.2) −0.2 (−13.1 to 12.7)
52 weeks 27.6 (23.7) 26.1 (23.9) 22.2 (23.7) 18.8 (23.9) 1.5 (−11.9 to 15.0) −5.5 (−18.8 to 7.9) −3.3 (−16.8 to 10.1)
Anterior knee pain scale (0-100)*:
6 weeks 79.7 (9.1) 74.8 (9.1) 83.4 (9.1) 83.6 (9.1) 4.9 (−0.4 to 10.2) 3.7 (−1.6 to 9.0) 0.2 (−5.0 to 5.5)
12 weeks 81.8 (9.9) 80.9 (9.9) 84.9 (9.9) 86.7 (9.9) 0.9 (−4.9 to 6.6) 3.1 (−2.5 to 8.8) 1.8 (−4.0 to 7.5)
52 weeks 85.5 (9.7) 86.9 (9.7) 87.9 (9.7) 91.5 (9.7) −1.5 (−7.3 to 4.4) 2.5 (−3.3 to 8.2) 3.6 (−2.5 to 9.7)
Functional index questionnaire (0-16)*:
6 weeks 11.8 (2.3) 11.1 (2.3) 12.9 (2.3) 13.3 (2.3) 0.7 (−0.6 to 2.0) 1.0 (−0.3 to 2.3) 0.5 (−0.8 to 1.8)
12 weeks 12.3 (2.3) 12.0 (2.3) 13.3 (2.3) 13.9 (2.3) 0.2 (−1.1 to 1.6) 1.0 (−0.3 to 2.4) 0.6 (−0.8 to 1.9)
52 weeks 13.0 (2.6) 13.4 (2.6) 14.2 (2.6) 13.8 (2.6) −0.5 (−1.9 to 1.0) 1.3 (−0.2 to 2.7) −0.5 (−1.9 to 1.0)
*Positive score favours reference group (first group listed in comparison).
†Significant at P=0.01.
‡Negative score favours reference group.
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1043 On the basis of
theseissues,weincludedinourrandomisedcontrolled
trial a flat shoe insert to evaluate the clinical efficacy of
thecontouredformoffootorthoses.
25Ourfindingsofa
clinically beneficial effect in favour of the contoured
orthoses provides a solid foundation on which to
considerthemechanismsofactionoffootorthosesand
plan future research.
Point estimates of effect between foot orthoses and
flat inserts were detected by using measures of global
improvement, but not by using measures of pain or
physical function, even though these measures were
sensitive to change over time within each group. This
reflects the moderate correlations between global
improvement rating scales and these measures of
pain and function reported by researchers
26 in their
evaluation of outcome measures used in their rando-
mised controlled trial.
19 They recommended that
clinical trials of patellofemoral pain syndrome incor-
porate a measure of perceived global response to
treatment, largely on the basis that this scale feasibly
encompasses many dimensions of patellofemoral pain
syndrome that are meaningful to the patient (for
example, pain, function, disability, participation,
psychosocial factors). It is likely that a rating of global
improvement captures more comprehensively the
patient experience, a notion that requires further
explorationtounderstandbettertheclinicalrelevance.
Strengths and limitations
The prescription of foot orthoses for musculoskeletal
pain is characterised by a lack of solid evidence from
quality clinical trials.
20 We studied the long term
efficacy of foot orthoses in the management of
patellofemoral pain syndrome. This is a clinically
importantissueastheconditionishighlyprevalentand
foot orthoses are prescribed worldwide. We incorpo-
rated the recommendations from the consolidated
standards of reporting trials into the methodological
design, which further strengthens the validity of
findings.
44 Importantly, the attrition rate was low,
with8%ofprimaryoutcomedatamissingatsixweeks,
10% at 12 weeks, and 4% at 52 weeks.
Unlike other clinical trials, we did not select those
treated with foot orthoses on the basis of foot posture
(for example, excessive pronation
22), largely because
no valid method currently exists to identify a priori
thosewhomaybenefitfromfootorthoses.Itispossible
that participants fitted with orthoses in our trial were
(randomly) heterogeneous for foot posture, yet we still
found small but beneficial effects of prescribing foot
orthosescomparedwithflatinserts.Conceivably,ifthe
classification of patients becomes possible,
45 then the
point estimates of effect we report are likely to be an
underestimate.
The characteristics of the participants in our trial
weresimilartothosereportedbyothersforage,height,
sex, proportion with bilateral patellofemoral pain
syndrome, duration of condition, severity of pain,
anterior knee pain scale, and functional index
questionnaire.
10193033 Feasibly this represents the
broader population of patients with patellofemoral
painsyndromewhovisitgeneralmedicalpracticesand
strengthens the external validity of the findings of our
study. Further reinforcing the external validity of our
findings we used physiotherapists from primary care
practices in the community, and with only a short
duration of training in the protocol (about 1.5 days)
they were able to successfully implement an effective
footorthosisintervention,whichhadasimilareffectto
the multimodal physiotherapy programme.
A limitation of this study is the number of
comparisons between groups. Although we used 99%
confidencelimittoassistincontroloftypeIerrors,itis
possible that the significant finding between foot
orthoses and flat inserts was due to chance. Notwith-
standing this, a number needed to treat of 4 could be
regarded as a clinically meaningful effect and in part
counters the possibility of a type I error in the
comparison of orthoses with flat inserts at six weeks.
A further limitation was that we did not include a
control group for clinical course so we cannot
Table 4 |Participantreporteduseofcointerventionsforpatellofemoralpainduringtrial*
Additional intervention
Foot orthoses
(n=40) Flat inserts (n=39)
Physiotherapy
(n=43)
Foot orthoses plus
physiotherapy(n=40) Total (n=162)
None 26 24 27 31 108
General practitioner or specialist 3 0 0 1 4
Physiotherapy 3 1 1 2 7
Foot orthoses 0 3† 10 4
Massage 1 0 1 0 2
Over counter drugs‡ 11 12 13 7 43
Prescription drugs‡ 010 0 1
Acupuncture 1 0 0 1 2
Complementary medicine 1 2 3 2 8
Heat rub 1 0 1 1 3
Ice or heat 4 0 1 1 6
Knee brace 1 0 0 1 2
*Some participants used more than one additional intervention.
†Includes two participants who crossed over to receive foot orthoses after 12 weeks as recommended by trial physiotherapists.
‡Analgesics and non-steroidal anti-inflammatory drugs.
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therapy were better than no treatment over 52 weeks.
Nevertheless,a casemaybemadeforinterveningwith
foot orthoses or physiotherapy as over 80% of
participants in our study were improved at 52 weeks,
comparedwith50%ofparticipantsfollowedupatfour
years in a prospective long term study of the clinical
course of patellofemoral pain syndrome.
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Conclusions
Prefabricatedfootorthosesaresuperiortoflatinsertsin
the short term management of patellofemoral pain
syndrome, implying that their contoured shape is
therapeutic. We found no differences between the
effects of foot orthoses and physiotherapy, nor was
there any benefit of adding foot orthoses to physio-
therapy.Consideringthatalltreatmentgroupsshowed
clinically meaningful long term improvements, gen-
eral practitioners may seek to hasten recovery by
prescribing foot orthoses.
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